Cost-effectiveness of presentation versus delayed troponin testing for acute myocardial infarction

Heart

Volumn 98, Issue 20, 2012, Pages 1498-1503

  Thokala, Praveen ^a   Goodacre, Steve W ^a   Collinson, Paul O ^b   Stevens, John W ^a   Mills, Nicholas L ^c   Newby, David E ^c   Morris, Francis ^d   Kendall, Jason ^e   Stevenson, Matt D ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e NORTH BRISTOL NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN I; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DECISION TREE; DELAYED DIAGNOSIS; DIAGNOSTIC TEST ACCURACY STUDY; ELECTROCARDIOGRAM; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROBABILITY; PROTEIN ANALYSIS; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; THORAX PAIN; UNITED KINGDOM;

ADULT; AGED; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DELAYED DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; QUALITY-ADJUSTED LIFE YEARS; TROPONIN;

EID: 84866600178     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-302188     Document Type: Article

References (20)

1. Thygesen K, Alpert JS, White HD, et al; On behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol 2007;50:2173-95. (Pubitemid 350123680)
2. Cooper A, Calvert N, Skinner J, et al. Chest Pain of Recent Onset: Assessment and Diagnosis of Recent Onset Chest Pain or Discomfort of Suspected Cardiac Origin, Clinical Guideline 95. London: National Clinical Guideline Centre for Acute and Chronic Conditions, 2010.
3. Hamm CW, Bassand J-P, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2011;32:2999-3054.
4. Goodacre SW, Bradburn M, Cross E, et al RATPAC Research Team. The Randomised Assessment of Treatment using Panel Assay of Cardiac Markers (RATPAC) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department. Heart 2011;97:190-6.
5. The NHS Health and Social Care Information Centre. Hospital Episodes Statistics for England, 1998-2010. 2011. http://www.hesonline.nhs.uk/
6. Reichlin T, Hochholzer W, Bassetti S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009;361:858-67.
7. Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-77.
8. Goodacre S, Bradburn M, Cross E, et al. The RATPAC (Randomised Assessment of Treatment using Panel Assay of Cardiac markers) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department. Health Technol Assess 2011;15:19-49.
9. Office for National Statistics (ONS). Interim Life Tables 2006-08. 2008.
10. Mills N, Churchhouse AMD, Lee KK, et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 2011;305:1210-16.
11. Goodacre S, Thokala P, Carroll C, et al. Cost-effectiveness of diagnostic strategies for suspected acute coronary syndrome (ACS). Health Technol Assess 2012. http:// www.hta.ac.uk/project/2269.asp
12. Polanczyk CA, Kuntz KM, Sacks DB, et al. Emergency department triage strategies for acute chest pain using creatine kinase-MB and troponin I assays: a costeffectiveness analysis. Ann Intern Med 1999;131:909-18. (Pubitemid 30005030)
13. Ward S, Lloyd JM, Pandor A, et al. A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol Assess 2007;11:1-160, iii-iv.
14. Department of Health (2010a). Tariff Information: Confirmation of Payment by Results (PbR) Arrangements for 2009-10. London: Department of Health, 2011.
15. Keller T, Zeller T, Ojeda FM, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 2011;306:2684-93.
16. Choi YF, Wong TW, Lau CC. The diagnostic value and cost effectiveness of creatine kinase-MB, myoglobin and cardiac troponin-T for patients with chest pain in emergency department observation ward. Hong Kong J Emerg Med 2004;11:85-90. (Pubitemid 38585045)
17. Zarich S, Bradley K, Seymour JW, et al. Impact of troponin T determinations on hospital resource utilization and costs in the evaluation of patients with suspected myocardial ischemia. Am J Cardiol 2001;88:732-6.
18. Mant J, Doust J, Roalfe A, et al. Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health Technol Assess 2009;13:1-207.
19. Goodacre S, Calvert N. Cost effectiveness of diagnostic strategies for patients with acute, undifferentiated chest pain. Emerg Med J 2003;20:429-33. (Pubitemid 37168217)
20. Skinner JS, Smeeth L, Kendall JM, et al Chest Pain Guideline Development Group. NICE guidance. Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin. Heart 2010;96:974-8.